Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
5,2 USD | -2,80% | -2,80% | +10,64% |
Métier
Nombre d'employés: 7
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/05/22 |
John Hamill
DFI | Director of Finance/CFO | 60 | 30/01/23 |
Zeev Weiss
PRN | Corporate Officer/Principal | 62 | 01/05/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01/01/15 |
John Henneman
BRD | Director/Board Member | 62 | 01/08/19 |
Rifat Pamukcu
BRD | Director/Board Member | 66 | 01/05/22 |
Jean Bizzari
BRD | Director/Board Member | 69 | 23/08/23 |
Oren Gilad
CEO | Chief Executive Officer | 56 | 01/05/22 |
Marc Duey
BRD | Director/Board Member | 68 | 01/05/22 |
Richard Peters
CHM | Chairman | 61 | 30/06/20 |
Director/Board Member | 70 | 01/05/22 | |
Gabriela Gruia
BRD | Director/Board Member | 67 | 05/05/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 56 227 | 0 | 0 | 83,50 % |
Action B | 1 | 5 430 215 | 4 534 187 ( 83,50 %) | 0 |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+10,64% | 28,24 M | |
+1,51% | 42,75 Md | |
+49,22% | 41,61 Md | |
+8,57% | 41,34 Md | |
-12,36% | 26,59 Md | |
+8,92% | 25,49 Md | |
-25,13% | 18,12 Md | |
+29,17% | 12,24 Md | |
-3,12% | 11,76 Md | |
+6,35% | 11 Md |
- Bourse
- Actions
- Action APRE
- Société Aprea Therapeutics, Inc.